Real-world single-center experience with 10 cases of generalized pustular psoriasis successfully treated with ixekizumab - 11/02/20
Doi : 10.1016/j.jaad.2019.09.040
Mayumi Nagata, MD a, Masahiro Kamata, MD, PhD a, ⁎ 
, Saki Fukaya, MD a, Kotaro Hayashi, MD, PhD a, Atsuko Fukuyasu, MD a, Takamitsu Tanaka, MD, PhD a, Takeko Ishikawa, MD, PhD a, Takamitsu Ohnishi, MD, PhD a, Kazumitsu Sugiura, MD, PhD b, Yayoi Tada, MD, PhD a
, Saki Fukaya, MD a, Kotaro Hayashi, MD, PhD a, Atsuko Fukuyasu, MD a, Takamitsu Tanaka, MD, PhD a, Takeko Ishikawa, MD, PhD a, Takamitsu Ohnishi, MD, PhD a, Kazumitsu Sugiura, MD, PhD b, Yayoi Tada, MD, PhD a a Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan
b Department of Dermatology, Fujita Health University, Toyoake, Japan
∗Correspondence to: Masahiro Kamata, MD, PhD, Department of Dermatology, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo 173-8605, Japan.Department of DermatologyTeikyo University School of Medicine2-11-1 Kaga, Itabashi-kuTokyo173-8605Japan
Abbreviations used : GPP, PASI, PASI 75, PASI 90, PASI 100
| Funding sources: None. |
|
| Disclosure: Dr Kamata received grants for research from Torii Pharmaceutical, Eisai, Maruho, and Novartis Pharma and honoraria for lectures from Torii Pharmaceutical, Maruho, LEO Pharma, Eisai, AbbVie, Kyowa Hakko Kirin, Eli Lilly, Taiho Pharmaceutical, Mitsubishi Tanabe Pharma, and Janssen Pharmaceuticals. |
|
| Dr Tada received grants for research from Maruho, LEO Pharma, Eisai, AbbVie, Kyowa Hakko Kirin, Taiho Pharmaceutical, Celgene, and Eli Lilly and honoraria for lectures from Torii Pharmaceutical, Maruho, LEO Pharma, Eisai, AbbVie, Kyowa Hakko Kirin, Eli Lilly, Taiho Pharmaceutical, Mitsubishi Tanabe Pharma, and Janssen Pharmaceuticals. Drs Nagata, Fukaya, Hayashi, Fukuyasu, Tanaka, Ishikawa, Ohnishi, and Sugiura have no conflicts of interest to declare. |
|
| IRB approval status: Approved by the Teikyo University Ethical Committee (19-080). |
© 2019
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 82 - N° 3
P. 758-761 - mars 2020 Retour au numéro
Article précédent
- Pattern hair loss: Assessment of inflammation and fibrosis on histologic sections
- Manuel Valdebran, Joshua Mo, Dirk M. Elston, Linda Doan
- Cost and utilization of immunotherapy and targeted therapy for melanoma: Cross-sectional analysis in the Medicare population, 2013 and 2015
- Kira Seiger, Chrysalyne D. Schmults, Ann W. Silk, Emily Stamell Ruiz
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?